Crossmark

Relationships of GDAP1 Mutations to Disease Phenotype and Mechanisms of Therapeutic Action of Oxidative Metabolism Activators in a Patient with Charcot–Marie–Tooth Neuropathy Type 2K

Crossref DOI link: https://doi.org/10.1134/S0006297925601911

Published Online: 2025-12-04

Published Print: 2025-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Borisova, Nadejda R.

Emelyanova, Alina A.

Solovjeva, Olga N.

Balashova, Natalia V.

Sidorova, Olga P.

Bunik, Victoria I.
License Information

Text and Data Mining valid from 2025-11-01

Version of Record valid from 2025-11-01
More Information

Article History

Received: 6 July 2025

Revised: 5 October 2025

Accepted: 18 October 2025

First Online: 4 December 2025

Ethics declarations

: Ethics approval and consent to participate. The study was approved by the Ethics Committee of Vladimirsky Moscow Regional Research and Clinical Institute (protocol no. 17, December 10, 2020). All the study participants provided voluntary informed consent. For the minor patient, the consent was provided by the mother.

: Conflict of interest. The authors of this work declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below